{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T22:02:26Z","timestamp":1779746546735,"version":"3.53.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302237"],"award-info":[{"award-number":["82302237"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2026NSFSC1779"],"award-info":[{"award-number":["2026NSFSC1779"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["ZYGD23016"],"award-info":[{"award-number":["ZYGD23016"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejmech.2026.118728","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:43:59Z","timestamp":1772178239000},"page":"118728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis and preclinical evaluation of a tumor extracellular nucleotidase CD73 targeted theranostic radiotracer"],"prefix":"10.1016","volume":"308","author":[{"given":"Chunyan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangli","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4896-4311","authenticated-orcid":false,"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejmech.2026.118728_bib1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","article-title":"The adenosine pathway in immuno-oncology","volume":"17","author":"Allard","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118728_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.18388\/abp.2012_2105","article-title":"Dual, enzymatic and non-enzymatic, function of ecto-5'-nucleotidase (eN, CD73) in migration and invasion of A375 melanoma cells","volume":"59","author":"Sadej","year":"2012","journal-title":"Acta Biochim. Pol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118728_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00432-007-0292-z","article-title":"Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells","volume":"134","author":"Wang","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118728_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1320011","article-title":"CD39\/CD73 upregulation on myeloid-derived suppressor cells via TGF-\u03b2-mTOR-HIF-1 signaling in patients with non-small cell lung cancer","volume":"6","author":"Li","year":"2017","journal-title":"OncoImmunology"},{"issue":"9","key":"10.1016\/j.ejmech.2026.118728_bib5","doi-asserted-by":"crossref","first-page":"14622","DOI":"10.1002\/jcp.28187","article-title":"CD73; a key ectonucleotidase in the development of breast cancer: recent advances and perspectives","volume":"234","author":"Soleimani","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118728_bib6","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/annonc\/mdx730","article-title":"Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial","volume":"29","author":"Buisseret","year":"2018","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118728_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jso.23056","article-title":"High expression of CD73 as a poor prognostic biomarker in human colorectal cancer","volume":"106","author":"Wu","year":"2012","journal-title":"J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118728_bib8","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jso.23159","article-title":"CD73 as a novel prognostic biomarker for human colorectal cancer","volume":"106","author":"Liu","year":"2012","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118728_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00428-020-02888-4","article-title":"Prognostic impact of CD73 expression and its relationship to PD-L1 in patients with radically treated pancreatic cancer","volume":"478","author":"Tahkola","year":"2021","journal-title":"Virchows Arch."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118728_bib10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00109-018-01742-0","article-title":"The distinct role of CD73 in the progression of pancreatic cancer","volume":"97","author":"Zhou","year":"2019","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"7","key":"10.1016\/j.ejmech.2026.118728_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072304","article-title":"Radiolabeled human monoclonal antibody 067-213 has the potential for noninvasive quantification of CD73 expression","volume":"21","author":"Sudo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118728_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-68987-3","article-title":"PET imaging of Colon cancer CD73 expression using cysteine site-specific 89Zr-labeled anti-CD73 antibody","volume":"14","author":"Jung","year":"2024","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118728_bib13","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1021\/acs.jmedchem.9b01713","article-title":"Discovery of potent and selective non-nucleotide small molecule inhibitors of CD73","volume":"63","author":"Beatty","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118728_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.apradiso.2012.10.014","article-title":"The untapped potential of Gallium 68-PET: the next wave of 68Ga-agents","volume":"76","author":"Smith","year":"2013","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ejmech.2026.118728_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.apradiso.2013.01.039","article-title":"Clinical applications of Gallium-68","volume":"76","author":"Banerjee","year":"2013","journal-title":"Appl. Radiat. Isot."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118728_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7150\/ijbs.87440","article-title":"Dual role of CD73 as a signaling molecule and adenosine-generating enzyme in colorectal cancer progression and immune evasion","volume":"20","author":"Lian","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"18","key":"10.1016\/j.ejmech.2026.118728_bib17","doi-asserted-by":"crossref","first-page":"10433","DOI":"10.1021\/acs.jmedchem.0c01086","article-title":"Orally bioavailable small-molecule CD73 inhibitor (OP-5244) reverses immunosuppression through blockade of adenosine production","volume":"63","author":"Du","year":"2020","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118728_bib18","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1021\/acs.molpharmaceut.2c00965","article-title":"Synthesis and preclinical evaluation of a novel FAPI-04 dimer for cancer theranostics","volume":"20","author":"Zhong","year":"2023","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118728_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061889","article-title":"Novel generation of FAP inhibitor-based homodimers for improved application in radiotheranostics","volume":"15","author":"Martin","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.ejmech.2026.118728_bib20","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1021\/acs.molpharmaceut.2c00424","article-title":"Development of fibroblast activation protein inhibitor-based dimeric radiotracers with improved tumor retention and antitumor efficacy","volume":"19","author":"Zhao","year":"2022","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118728_bib21","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1021\/acs.bioconjchem.7b00378","article-title":"Synthesis, radiolabeling, and characterization of plasma protein-binding ligands: potential tools for modulation of the pharmacokinetic properties of (radio)Pharmaceuticals","volume":"28","author":"M\u00fcller","year":"2017","journal-title":"Bioconjug. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118728_bib22","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1021\/acs.jmedchem.1c02162","article-title":"Rational design and pharmacomodulation of protein-binding Theranostic radioligands for targeting the fibroblast activation protein","volume":"65","author":"Meng","year":"2022","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118728_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41181-025-00328-9","article-title":"Lutetium-177 labeled iPD-L1 as a novel immunomodulator for cancer-targeted radiotherapy","volume":"10","author":"Luna-Guti\u00e9rrez","year":"2025","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118728_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1039\/D4TB01798F","article-title":"Advancing cancer therapy with a heptamethine carbocyanine dye-conjugated radionuclide drug","volume":"13","author":"Huang","year":"2024","journal-title":"J. Mater. Chem. B"},{"issue":"2","key":"10.1016\/j.ejmech.2026.118728_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11307-019-01404-8","article-title":"Preclinical dosimetry, imaging, and targeted radionuclide therapy studies of Lu-177-Labeled albumin-Binding, PSMA-targeted CTT1403","volume":"22","author":"Ling","year":"2020","journal-title":"Mol. Imag. Biol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118728_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00432-024-05869-1","article-title":"Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma","volume":"150","author":"Sun","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600173X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600173X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T21:06:59Z","timestamp":1779743219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342600173X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":26,"alternative-id":["S022352342600173X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118728","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and preclinical evaluation of a tumor extracellular nucleotidase CD73 targeted theranostic radiotracer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118728"}}